7197-01-5

Basic information

• Product Name: 6-CHLORO-3-METHYL[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE
• Synonyms: 1,2,4-TRIAZOLO[4,3-B]PYRIDAZINE, 6-CHLORO-3-METHYL-;AKOS BBS-00003074;6-CHLORO-3-METHYL[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE
• CAS NO: 7197-01-5
• Molecular Formula: C₆H₅ClN₄
• Molecular Weight: 168.58
• Mol File: 7197-01-5.mol
• Article Data: 12

Chemical Properties

• Melting Point: 104-105 °C
• Appearance: /
• Density: 1.59 g/cm³
• Refractive Index: 1.743
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 0.04±0.30(Predicted)
• CAS DataBase Reference: 6-CHLORO-3-METHYL[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-CHLORO-3-METHYL[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE(7197-01-5)
• EPA Substance Registry System: 6-CHLORO-3-METHYL[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE(7197-01-5)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 7197-01-5(Hazardous Substances Data)

Usage

General Description

6-Chloro-3-methyl[1,2,4]triazolo[4,3-b]pyridazine is a specialized chemical compound that falls under the category of triazolopyridazines, which consist of a pyridazine ring fused with a triazole ring. 6-Chloro-3-methyl[1,2,4]triazolo[4,3-b]pyridazine, like others in its category, possesses notable properties that potentially serve in various applications, particularly in medicinal chemistry, given the presence of bio-active molecules. However, detailed information regarding its in-depth chemical properties, toxicity, potential uses, or biological activity is not widely available in the literature, indicating that this chemical is a subject of niche interest and study within the scientific community.

InChI:InChI=1/C6H5ClN4/c1-4-8-9-6-3-2-5(7)10-11(4)6/h2-3H,1H3

Upstream product

• 158607-18-2 3-(2,3-dibromo-2-ethylidenehydrazino)-6-chloropyridazine 
• 64-19-7 acetic acid 
• 7190-92-3 6-chloro-3-ethylidenehydrazinopyridazine 
• 17284-97-8 3-Chloro-6-hydrazinopyridazine 
• 78-39-7 Triethyl orthoacetate 
• 141-30-0 3,6-dichlorpyridazine 
• 1068-57-1 acetic acid hydrazide 
• 59681-36-6 4-acetylhydrazinomethylene-2-phenyloxazol-5(4H)-one 
• 32894-07-8 S-benzyl thioacetimidate hydrochloride 
• 17284-97-8 3-chloro-6-hydrazinopyridazine 
• 570-08-1 diethyl acetylmalonate 
• 1445-45-0 Trimethyl orthoacetate 
• 80140-14-3 1-acetyl-2-(6-chloro-3-pyridazinyl)-hydrazine 
• 108-24-7 acetic anhydride 

Downstream Products

• 1353880-76-8 N-benzyl-2,4-dimethyl-2-(((3-methyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy)methyl)-3,4-dihydro-2H-1,4-benzoxazin-7-amine 
• 1353880-77-9 N-(4-fluorobenzyl)-2,4-dimethyl-2-(((3-methyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy)methyl)-3,4-dihydro-2H-1,4-benzoxazin-7-amine 
• 1353880-78-0 N-(3,5-difluorobenzyl)-2,4-dimethyl-2-(((3-methyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy)methyl)-3,4-dihydro-2H-1,4-benzoxazin-7-amine 
• 1353880-82-6 ethyl 2-(benzyl(2,4-dimethyl-2-(((3-methyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy)methyl)-3,4-dihydro-2H-1,4-benzoxazin-7-yl)amino)-2-oxoacetate 
• 1353880-83-7 ethyl 2-((2,4-dimethyl-2-(((3-methyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy)methyl)-3,4-dihydro-2H-1,4-benzoxazin-7-yl)(4-fluorobenzyl)amino)-2-oxoacetate 
• 1353880-84-8 ethyl 2-((3,5-difluorobenzyl)(2,4-dimethyl-2-(((3-methyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy)methyl)-3,4-dihydro-2H-1,4-benzoxazin-7-yl)amino)-2-oxoacetate 
• 1353880-88-2 2-(benzyl(2,4-dimethyl-2-(((3-methyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy)methyl)-3,4-dihydro-2H-1,4-benzoxazin-7-yl)amino)-2-oxoacetic acid 
• 1353880-89-3 2-((2,4-dimethyl-2-(((3-methyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy)methyl)-3,4-dihydro-2H-1,4-benzoxazin-7-yl)(4-fluorobenzyl)amino)-2-oxoacetic acid 
• 1353880-90-6 2-((3,5-difluorobenzyl)(2,4-dimethyl-2-(((3-methyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy)methyl)-3,4-dihydro-2H-1,4-benzoxazin-7-yl)amino)-2-oxoacetic acid 
• 65559-68-4 3-Methyl-6-phenyl-s-triazolo<4,3-b>pyridazine 

Relevant articles and documents

ARYLACETAMIDE ANALOGS OF PIPERAZINE-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINES

Provided are compounds with the following structure: Formula (I), and methods of making and using same. The methods of using the compounds may be methods for treating or prophylaxis of a cryptosporidium infection.

Synthesis and bioevaluation of 6-chloropyridazin-3-yl hydrazones and 6-chloro-3-substituted-[1,2,4]triazolo[4,3-b]pyridazines as cytotoxic agents

An efficient synthesis of a series of 6-chloro-3-substituted-[1,2,4]triazolo[4,3-b]pyridazines is described via intramolecular oxidative cyclization of various 6-chloropyridazin-3-yl hydrazones with iodobenzene diacetate. The structures of the newly synth

TRIAZOLO COMPOUNDS

The present invention relates to compounds of formula (I) and its use for the treatment of neurological disorders.